NCT01365494View on ClinicalTrials.gov

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Rabies
Interventions
BIOLOGICAL

Purified Chick Embryo Cell Inactivated Rabies Vaccine

Two group (Zagreb and Essen) will receive Rabipur vaccine IM according to either Zagreb or Essen schedules.

Trial Locations (3)

411018

Padmashree Dr. D.Y Patil Hospital, Pune

560070

Kempegowda Institute of Medical Sciences Hospital (KIMS), Bangalore

571401

Mandya Institute of Medical Sciences, Mandya

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY